Literature DB >> 11445240

Neuropeptides interact with glycolipid receptors: a surface plasmon resonance study.

T Valdes-Gonzalez1, J Inagawa, T Ido.   

Abstract

Using Surface Plasmon Resonance (SPR) we investigated the interaction of seven neuropeptides with different characteristics and beta-amyloid (Abeta42) peptide, with membranes containing gangliosides. A wide range of affinities characterized the bindings (K(D) = 10(-3)- 10(-7) M), following the scheme: for GM1, Abeta42 > DYN > SP = GAL = SOM = BRD > OXY = ENK; for GD1a, Abeta42 = DYN = GAL > SP = SOM = BRD = OXY > ENK and for GT1b, Abeta42 > DYN > SP = GAL > SOM = BRD = OXY > ENK. The ganglioside sugar moiety, specifically the sialic acid, had an important role in the interactions. In general the affinities were higher with polysialo, than with monosialo gangliosides. The sensorgrams describing the interactions of Abeta42 and SP with gangliosides differed from the interactions of the other studied peptides. Ca(2+) promoted changes in peptide-glycolipid interactions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11445240     DOI: 10.1016/s0196-9781(01)00432-6

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  9 in total

Review 1.  Role of ganglioside metabolism in the pathogenesis of Alzheimer's disease--a review.

Authors:  Toshio Ariga; Michael P McDonald; Robert K Yu
Journal:  J Lipid Res       Date:  2008-03-11       Impact factor: 5.922

Review 2.  Surface plasmon resonance for the analysis of beta-amyloid interactions and fibril formation in Alzheimer's disease research.

Authors:  Marie-Isabel Aguilar; David H Small
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

Review 3.  Impact of GM1 on Membrane-Mediated Aggregation/Oligomerization of β-Amyloid: Unifying View.

Authors:  Marek Cebecauer; Martin Hof; Mariana Amaro
Journal:  Biophys J       Date:  2017-04-11       Impact factor: 4.033

Review 4.  Deregulated sphingolipid metabolism and membrane organization in neurodegenerative disorders.

Authors:  Marco Piccinini; Federica Scandroglio; Simona Prioni; Barbara Buccinnà; Nicoletta Loberto; Massimo Aureli; Vanna Chigorno; Elisa Lupino; Giovanni DeMarco; Annarosa Lomartire; Maria Teresa Rinaudo; Sandro Sonnino; Alessandro Prinetti
Journal:  Mol Neurobiol       Date:  2010-02-03       Impact factor: 5.590

5.  How cholesterol constrains glycolipid conformation for optimal recognition of Alzheimer's beta amyloid peptide (Abeta1-40).

Authors:  Nouara Yahi; Anaïs Aulas; Jacques Fantini
Journal:  PLoS One       Date:  2010-02-05       Impact factor: 3.240

6.  Biochemical identification of a linear cholesterol-binding domain within Alzheimer's β amyloid peptide.

Authors:  Coralie Di Scala; Nouara Yahi; Clément Lelièvre; Nicolas Garmy; Henri Chahinian; Jacques Fantini
Journal:  ACS Chem Neurosci       Date:  2012-12-27       Impact factor: 4.418

7.  Attenuation of beta-amyloid-induced toxicity by sialic-acid-conjugated dendrimers: role of sialic acid attachment.

Authors:  Dhara A Patel; James E Henry; Theresa A Good
Journal:  Brain Res       Date:  2007-06-09       Impact factor: 3.252

Review 8.  Molecular insights into amyloid regulation by membrane cholesterol and sphingolipids: common mechanisms in neurodegenerative diseases.

Authors:  Jacques Fantini; Nouara Yahi
Journal:  Expert Rev Mol Med       Date:  2010-09-01       Impact factor: 5.600

9.  Scavenging amyloid oligomers from neurons with silica nanobowls: Implications for amyloid diseases.

Authors:  Vrinda Sant; Madhura Som; Abhijith G Karkisaval; Parker Carnahan; Ratnesh Lal
Journal:  Biophys J       Date:  2021-07-07       Impact factor: 3.699

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.